The optimizing asthma control programs will review key learnings from The Saudi Initiative for Asthma 2019 Update: Guidelines for the diagnosis and management of asthma in adults and children and The Global Initiative for Asthma (GINA) 2018 guidelines. The second program will provide clinicians with the appropriate management of people with mild to moderate asthma.
This program has received an unrestricted educational grant or in-kind support from AstraZeneca.